Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Vanni

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinics in Liver Disease|November 27, 2013
Obesity and liver cancerEster Vanni, Elisabetta Bugianesi
Hepatology (Baltimore, Md.)|May 29, 2009
The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?Ester Vanni, Elisabetta Bugianesi
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2014
Response to Dr. Sertoglu and colleaguesSalvatore Petta, Ester Vanni, Antonio Craxì
Current Diabetes Reports|June 6, 2007
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetesElisabetta Bugianesi, Ester Vanni, Giulio Marchesini
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 23, 2016
Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?"Ester Vanni, Elisabetta Bugianesi, Giorgio Maria Saracco
Seminars in Liver Disease|September 18, 2015
Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent BystanderEster Vanni, Andrea Marengo, Lavinia Mezzabotta, et al.
Diabetes Care|May 31, 2007
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in childrenValerio Nobili, Matilde Marcellini, Giulio Marchesini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 9, 2010
From the metabolic syndrome to NAFLD or vice versa?Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, et al.
Hepatology (Baltimore, Md.)|June 28, 2005
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseNicola Villanova, Simona Moscatiello, Stefano Ramilli, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinics in Liver Disease|November 27, 2013
Obesity and liver cancerEster Vanni, Elisabetta Bugianesi
Hepatology (Baltimore, Md.)|May 29, 2009
The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance?Ester Vanni, Elisabetta Bugianesi
Liver International : Official Journal of the International Association for the Study of the Liver|August 19, 2014
Response to Dr. Sertoglu and colleaguesSalvatore Petta, Ester Vanni, Antonio Craxì
Current Diabetes Reports|June 6, 2007
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetesElisabetta Bugianesi, Ester Vanni, Giulio Marchesini
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 29, 2015
Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?Ester Vanni, Elisabetta Bugianesi, Giorgio Saracco
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 23, 2016
Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?"Ester Vanni, Elisabetta Bugianesi, Giorgio Maria Saracco
Seminars in Liver Disease|September 18, 2015
Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent BystanderEster Vanni, Andrea Marengo, Lavinia Mezzabotta, et al.
Diabetes Care|May 31, 2007
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in childrenValerio Nobili, Matilde Marcellini, Giulio Marchesini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 9, 2010
From the metabolic syndrome to NAFLD or vice versa?Ester Vanni, Elisabetta Bugianesi, Anna Kotronen, et al.
Hepatology (Baltimore, Md.)|June 28, 2005
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseNicola Villanova, Simona Moscatiello, Stefano Ramilli, et al.
Pageof 5